Stocks up…Spain imports Ebola drug…Barneys to pay $525K to settle profiling probe

NEW YORK (AP) — Stocks are higher in morning trading on Wall Street. Russia’s ending of military exercises near Ukraine and its withdrawal of troops to their bases is easing concerns about a possible invasion of Ukraine. Tame inflation in China also is boosting investors’ outlook. With overseas markets making healthy gains, the Dow has added 50 points in the first hour of trading, while the S&P 500 is up 9 points, and the Nasdaq composite has gained 30.

NEW YORK (AP) — Priceline is among the biggest gainers on Wall Street this morning. Shares were up more than 2.5 percent after the company reported second-quarter earnings that beat the expectations of Wall Street analysts. The company says the summer travel season got off to a good start for the online booking company.

MADRID (AP) — Spain says it has imported an experimental Ebola drug from the U.S. to treat a Spanish missionary priest infected with the killer virus. The Spanish Health Ministry statement comes less than a week after the U.S. Centers for Disease Control and Prevention said there were virtually no doses available of the drug used to treat two Americans with the disease. Nigerian officials say they’ve asked about getting the drug but so far have had no success. The ethical questions surrounding experimental Ebola drugs and vaccines are being debated today in a teleconference organized by the U.N. health agency.

NEW YORK (AP) — Barneys has agreed to pay $525,000 to settle allegations of racial profiling at its flagship New York City department store. The agreement comes after several customers complained last year that they were singled out as suspected shoplifters because they were minorities. New York Attorney General Eric Schneiderman says Barney’s will hire an “anti-profiling consultant”, update its detention policy and improve training of security and sales personnel.

BOSTON (AP) — The former CEO of the Market Basket supermarket chain says “onerous” terms are preventing him from buying a controlling share from relatives. Arthur T. Demoulas (deh-MOO’-lahs) says his offers to buy the company “have been rejected, not on the basis of price,” but with counterproposals “far beyond comparable transactions.” Demoulas was fired in June by a board controlled by his rival cousin, Arthur S. Demoulas.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up